Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease have?
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease has 292 citations in the OpenAlex counts ScholarIQ stores.
When was Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease published?
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease has 2009 year in the ScholarIQ index.
What is the open-access status of Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease has bronze oa status in the ScholarIQ index.
What is the DOI of Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
The DOI for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is on the source record.
What is the PMID of Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
The PMID for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is on the source record.
What is the OpenAlex record for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease?
The OpenAlex for Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease is on the source record.